Skip Navigation

European Journal of Heart Failure 2002 4(2):147-149; doi:10.1016/S1388-9842(01)00220-3
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Richardt, G.
Right arrow Articles by Kurz, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richardt, G.
Right arrow Articles by Kurz, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2002 European Society of Cardiology

Unique effects of carvedilol on noradrenaline release in the human heart

G. Richardta,*, D. Richardta, S. Adlera, E. Kraatzb, A. Nötzoldb and T. Kurza

a Universitätsklinikum Lübeck, Medizinische Klinik II Ratzeburger Allee 160, 23538, Lübeck, Germany
b Klinik für Herzchirurgie Universitätsklinikum Lübeck, Germany

* Corresponding author. Tel.: +49-451-500-2420; fax: +49-451-500-2363. E-mail address: gert.richardt@medinf.mu-luebeck.de

Received July 13, 2001; Accepted October 3, 2001

The first 10% of the full text of this article appears below.


   1. Background
 
The efficacy of carvedilol in patients with heart failure documented in the Carvedilol Post-Infarct Survival Control in LV Dysfunction (CAPRICORN) study [1] and the Carvedilol Prospective Randomized Cumulative Survival Trial (COPERNICUS) study [2] has generated a debate over whether the salutary effects of carvedilol are strictly a class effect caused by β-adrenergic receptor . . . [Full Text of this Article]


   2. Aim of the study
 

   3. Methods
 

   4. Results
 

   5. Conclusions
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Clin PharmacolHome page
B. F. McBride and C. M. White
Critical Differences Among Beta-Adrenoreceptor Antagonists in Myocardial Failure: Debating the MERIT of COMET
J. Clin. Pharmacol., January 1, 2005; 45(1): 6 - 24.
[Abstract] [Full Text] [PDF]